Clinical Trial Update: Comparing the Efficacy of Nitazoxanide Versus Rifaximin in Adult Patients With Irritable Bowel Syndrome Without Constipation [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial comparing nitazoxanide and rifaximin in adults with irritable bowel syndrome with diarrhea has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Irritable Bowel Syndrome with Diarrhea

Drugs mentioned

• Nitazoxanide (nitazoxanide)
• Rifaximin (rifaximin)

Snippet

Sponsor: Sadat City University | Conditions: Irritable Bowel Syndrome With Diarrhea | Phase 1, Phase 2 | Status: WITHDRAWN